The geography of antidepressant, Antipsychotic, And stimulant utilization in the United States

Health and Place

Volumn 20, Issue , 2013, Pages 32-38

  King, Marissa ^a   Essick, Connor ^b  

^a YALE SCHOOL OF MANAGEMENT   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Access to care; Antidepressant; Antipsychotic; Geography; Pharmaceutical marketing; Stimulant

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT;

DATA SET; DRUG; HEALTH CARE; HEALTH GEOGRAPHY; MARKETING; MENTAL HEALTH;

ARTICLE; CLUSTER ANALYSIS; DRUG MARKETING; DRUG UTILIZATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; TREND STUDY; UNITED STATES;

UNITED STATES;

EID: 84873882066     PISSN: 13538292     EISSN: 18732054     Source Type: Journal    
DOI: 10.1016/j.healthplace.2012.11.007     Document Type: Article

References (27)

1. Andersen Ronald Behavioral Model of Families' Use of Health Services 1968, Canter for Health Administration Studies, University of Chicago, Chicago, IL.
2. Andersen Ronald Revisiting the behavioral model and access to medical care: does it matter?. Journal of Health and Social Behavior 1995, 36(1):1-10. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/7738325.
3. CDC Current depression among adults-United States, 2006 and 2008. Morbidity and Mortality Weekly Report 2010, 59:1229-1235.
4. Cox E.R., et al. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics 2003, 111(2):237-243. (accessed May 4, 2012). http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.111.2.237.
5. Dubois R.W., Batchlor E., Wade S. Geographic variation in the use of medications: is uniformity good news or bad?. Health Affairs 2002, 21(1):240-250. (accessed July 11, 2012). http://content.healthaffairs.org/cgi/doi/10.1377/hlthaff.21.1.240.
6. Habel L., et al. Treatment with stimulants among youths in a large California Health Plan. Journal of Child and Adolescent Psychopharmacology 2005, 15(1):62-67.
7. Hoagwood K., et al. 2000 Medication management of stimulants in pediatri practice settings.pdf. Developmental and Behavioral Pediatrics 2000, 21:322-331.
8. IMS Health Incorporated, 2010. Top U.S Pharmaceutical Products by Spending, Available at: http://www.imshealth.com/deployedfiles/ims/Global/Content/Corporate/PressRoom/Top-lineMarketData/2010Top-lineMarketData/2010_Top_Products_by_Sales.pdf.
9. Kulldorff M., Nagarwalla N. Spatial disease clusters: detection and inference. Statistics in Medicine 1995, 14(8):799-810. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/7644860.
10. Kulldorff, Martin Information Management Services, 2009. SaTScan v8.0: Software for the Spatial and Space-Time Scan Statistics. Available at: http://www.satscan.org/.
11. Lin S.-J., Crawford S.Y., Lurvey P.L. Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan. Social Science & Medicine (1982) 2005, 60(3):617-626.
12. Mazumdar S., et al. The spatial structure of autism in California, 1993-2001. Health & Place 2010, 16(3):539-546. (accessed March 14, 2012). http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2835822&tool=pmcentrez&rendertype=abstract.
13. Olfson M., et al. National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41(5):514-521. (accessed July 3, 2012). http://www.ncbi.nlm.nih.gov/pubmed/12014783.
14. Patel N.C., et al. Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44(6):548-556. (accessed May 18, 2012). http://www.ncbi.nlm.nih.gov/pubmed/15908837.
15. Phillips K.A., et al. Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Services Research 1998, 33(3 Pt 1):571-596. Available at:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1070277&tool=pmcentrez&rendertype=abstract.
16. Pickett K.E., Pearl M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. Journal of Epidemiology and Community Health 2001, 55(2):111-122. Available at:. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1731829&tool=pmcentrez&rendertype=abstract.
17. ProPublica, 2011. Dollars for Docs. Available at: June 6, 2011 (accessed June 6, 2011). http://projects.propublica.org/docdollars/.
18. Rappley M., et al. The use of methylphenidate in Michigan. Archives of Pediatric and Adolescent Medicine 1995, 149:675-679.
19. Rosenthal M.B., Zaslavsky A., Newhouse J.P. The geographic distribution of physicians revisited. Health Services Research 2005, 40(6 Pt 1):1931-1952. (accessed May 14, 2012). http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361233&tool=pmcentrez&rendertype=abstract.
20. Silverman B.W. Choosing the window width when a density estimating. Biometrika 1978, 65(1):1-11.
21. Sirovich B., et al. Discretionary decision making by primary care physicians and the cost of U.S. Health care. Health Affairs (Project Hope) 2008, 27(3):813-823. (accessed November 2, 2012). http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2438037&tool=pmcentrez&rendertype=abstract.
22. The Express Scripts Research and New Solutions Lab, 2012. 2011 Drug Trend Report, aAvailable at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=15230.
23. Vitiello B., Zuvekas S.H., Norquist G.S. National estimates of antidepressant medication use among U.S. children, 1997-2002. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45(3):271-279. (accessed July 3, 2012). http://www.ncbi.nlm.nih.gov/pubmed/16540811.
24. Wang, C.-C. & Farley, J.F., 2009. Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey. Research in social & administrative pharmacy□: RSAP. Available at: (accessed July 3, 2012). http://www.ncbi.nlm.nih.gov/pubmed/21272525.
25. Weich S., et al. Geographical variation in rates of common mental disorders in Britain: prospective cohort study. The British Journal of Psychiatry: The Journal of Mental Science 2005, 187:29-34. (accessed July 11, 2012). http://www.ncbi.nlm.nih.gov/pubmed/15994568.
26. Zito J.M., et al. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology 2007, 17(2):195-203. (accessed May 18, 2012). http://www.ncbi.nlm.nih.gov/pubmed/17489714.
27. Zuvekas S.H., et al. Recent trends in stimulant medication use among U.S. children. The American Journal of Psychiatry 2006, 579-585.